Monthly Archives: November 2015

Portfolio performance November

Portfolio performance November

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

In general, November was a fine month. Shares went up and my portfolio performance was good with 9 out of 13 shares rising. Of the 13 shares, 6 were up more that 15%, 4 between app. 0 and 10 % and only 3 fell . On a year-to-date-basis, the portfolio is up 60 %. Continue reading

Portfolio short news

Portfolio short news week 47

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

The past weeks have been good to my portfolio. In general shares have gone up, and some quite a lot. The short news this week will follow up on new developments in AroCell, IVISYS, Recyctec, Phase Holographic and a new company on this blog: A1M Pharma which came by as a surprise, even to me. Continue reading

Photocat

Photocat at First North

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

Friday Photocat had its debut at First North, Stockholm. After the IPO in October, Friday 20th November was the first day of trading. The IPO in October did not raise all the money to finance the development as planned. In my latest post on the Photocat IPO and after I expressed doubts on the faith of my investments and foresaw cheap shares by Christmas. It was therefor with withheld breath and a pounding heart I followed the trade on First North on Friday. Judged by the performance, though, investors do not flee Photocat. The share ended at 31.7 SEK, which is 9.3 % up from the IPO price of 29 SEK. And for a while I am relieved because I still find there is a potential in the share! Continue reading

Homo Nervousus

IVISYS made the day!

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

Friday was an amazing day at Nasdaq Nordic. Ah no, it really was not, large cap went down by app. 1%, but one share made the day: IVISYS. And how it made it! Going up more than 60%. Then suspended from trade and the CEO announcing that there are no reason for a 50 % rise in share price! I was happy selling all of my shares at 14.25, and half an hour later, the trade was suspended at 13.15. On Monday, the share will drop like a stone… and “I’ll be back” as Arnold Schwarzenegger says in Austrian-English in Terminator I.

What happened on Friday is one of the fascinating thing about being an investor in penny shares or growth shares. Continue reading

Portfolio short news

Portfolio short news week 45

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

In the past week, a number of press releases have occurred regarding the companies in my portfolio of growth shares. I collect these news in a portfolio short news post. Readers of my blog knows that the prime driver of share prices in growth shares lies in the press releases – and not in changed guidance as with large cap shares. Therefor the press releases are worth reading an commenting upon. This week there are news from AroCell, Heliospectra, Fortnox, CybAero, and G5 Entertainment. Continue reading

AroCell share issue

AroCell share issue

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

Friday 6 November, AroCell announced a preferential rights issue. The aim is to rise 52.2 MSEK for the clinical development and validation of the cancer test-kit developed by the company. The share issue is fully guaranteed, meaning that if no current shareholders wish to invest, other investors will. Along the issue, the company announced its intention to change listing from Aktietorget to First North. Continue reading

Issues

Penny shares, frimärksaktier, Kleinaktien

Facebooktwittergoogle_pluslinkedinmailFacebooktwittergoogle_pluslinkedinmail

‘Penny shares’ or ‘penny stocks’ it the term for shares with a low price. Shares with a price below 1 GBP in the UK, 1€ in Germany, 5$ in the US and 5-10 DKK or SEK in Denmark and Sweden. In Danish and Swedish, the term is ‘stamp share’ (‘frimärksaktie’ in Swedish, ‘frimærkeaktie’ in Danish) referring to the similarity of price of sending a letter and the share price. In Germany, the term is ‘Kleinaktien’ – small share – refers, I guess, not as much to the physical size of the share, but the company behind. Continue reading